Among the different possibilities suggested, an alteration in the transforming growth factor-β1 (TGF-β1)/Smad3 signalling pathway has been considered to play a central role and is associated with lung fibrosis. The gene discussed is SMAD3; the disease is pulmonary fibrosis.